China Universal Asset Management »

Verve Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $79k 16k 4.84
2024-06-30 $48k 9.9k 4.88
2024-03-31 $213k 16k 13.28
2023-12-31 $123k 8.8k 13.94
2023-09-30 $22k 1.6k 13.26
2023-06-30 $15k 812 18.75
2023-03-31 $12k 835 14.42
2022-12-31 $12k 626 19.35
2022-09-30 $19k 561 33.87

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Verve Therapeutics

Alphabet
BlackRock
BlackRock
Vanguard Group
Casdin Capital
State Street Corporation
T. Rowe Price Investment Management
Schonfeld Strategic Advisors
Novo A/S
Arch Venture Corp
Baker Bros. Advisors
Jpmorgan Chase & Co
Geode Capital Management
Jacobs Levy Equity Management
Redmile Group

View all funds holding Verve Therapeutics